206 care center directors sign a letter citing clinical consequences if decision moves forward.
Site Search
Showing 1 - 3 of 3 results
News
|
Dec. 19, 2022
|
3 min read
If you receive financial assistance from Vertex GPS™ for a modulator therapy (e.g., Trikafta®, Symdeko®, Orkambi®, or Kalydeco®), you may be impacted by changes Vertex has made to its copay assistance program. The following tips can help you understand how you may be impacted and what next steps may be available to you.
Jonathan Grant, PharmD, BCACP
|
6 min read
Vertex’s copay assistance changes add an undue burden for people living with an already expensive, challenging lifelong disease.
News
|
Nov. 23, 2022
|
3 min read